Does DULOXETINE Cause Malignant neoplasm progression? 30 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Malignant neoplasm progression have been filed in association with DULOXETINE (Duloxetine Hydrochloride). This represents 0.1% of all adverse event reports for DULOXETINE.
30
Reports of Malignant neoplasm progression with DULOXETINE
0.1%
of all DULOXETINE reports
15
Deaths
4
Hospitalizations
How Dangerous Is Malignant neoplasm progression From DULOXETINE?
Of the 30 reports, 15 (50.0%) resulted in death, 4 (13.3%) required hospitalization, and 1 (3.3%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DULOXETINE. However, 30 reports have been filed with the FAERS database.
What Other Side Effects Does DULOXETINE Cause?
Nausea (7,355)
Dizziness (6,983)
Drug withdrawal syndrome (6,503)
Headache (5,541)
Fatigue (5,309)
Insomnia (5,270)
Anxiety (4,973)
Paraesthesia (4,854)
Drug ineffective (4,829)
Hyperhidrosis (4,101)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which DULOXETINE Alternatives Have Lower Malignant neoplasm progression Risk?
DULOXETINE vs DUPILUMAB
DULOXETINE vs DURAGESIC
DULOXETINE vs DUROGESIC
DULOXETINE vs DUROTEP MT
DULOXETINE vs DURVALUMAB